Lancets Market

Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to 2024

Report Code: MD 7166 Jun, 2019, by marketsandmarkets.com

[107 Pages Report] The lancets market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4% between 2019 and 2024. Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the lancets market during the forecast period. However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.

Lancets Market

The hospitals and clinics segment to dominate the lancets market in 2019

By end user, the lancets market is segmented into hospitals and clinics, home care settings, and other end users (diagnostic centers and pathology laboratories). In 2019, the hospitals and clinics segment is expected to dominate the lancets market. The dominant share of this segment is primarily attributed to the availability of a large patient pool and the increasing prevalence of infectious diseases that require blood testing for diagnosis and treatment.

Lancets Market

The APAC market is expected to grow at the highest CAGR during the forecast period

North America is projected to dominate the lancets market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period. The growing healthcare industry, rising geriatric population in China and India, rapid economic growth, and rising awareness about diabetes treatment are some of the key factors driving the growth of the lancets market in the Asia Pacific region.

Key Market Players

Prominent players in the lancets market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

Roche Diagnostics (Switzerland) is the diagnostics division of F. Hoffmann-La Roche AG. The company develops and manufactures equipment and reagents used for research and medical diagnostic applications. Roche operates through four business segments, namely, Centralized and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. The company offers lancets to various end users including physicians, hospitals, clinics, academic institutes, and for personal use through its Diabetes Care segment.

Recent Developments

  • In 2018, HTL-STREFA expanded its storage capacity in Leczyca by almost 50%, with an equivalent of 3,550 m2 additional storage space.
  • In 2018, HTL-STREFA was acquired by Investindustrial. This acquisition helped the companies partner for diabetes management, thus serving an extensive customer base.
  • In 2017, Owen Mumford opened its new facility in Malaysia to strengthen and accelerate the growth of the company in the Asia Pacific region.

Critical questions answered in the report:

  • Which regions are likely to grow at the highest CAGR?
  • What are the recent trends affecting the lancets market?
  • Who are the key players in the market and how intense is the competition?
  • What are the application areas of lancets?
  • What are the challenges hindering the adoption of lancets?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 15)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Data Validation and Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 28)
    4.1 Lancets Market Overview
    4.2 North America: Lancets Market, By Type, 2018
    4.3 Europe: Lancets Market, By Type, 2018
    4.4 Lancets Market: Geographic Snapshot

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Prevalence of Diabetes
                    5.2.1.2 High Prevalence of Infectious Diseases
           5.2.2 Restraints
                    5.2.2.1 Risk of Needlestick Injuries
                    5.2.2.2 Poor Reimbursement Scenario in Developing Countries
           5.2.3 Opportunities
                    5.2.3.1 High Growth Prospects in Emerging Countries
           5.2.4 Challenges
                    5.2.4.1 Reuse of Lancets

6 Lancets Market, By Type (Page No. - 36)
    6.1 Introduction
    6.2 Safety Lancets
           6.2.1 Push-Button Lancets
                    6.2.1.1 Ease of Use and Simplicity have Driven Demand for Push-Button Lancets
           6.2.2 Pressure-Activated Lancets
                    6.2.2.1 These Lancets are Available in A Number of Gauge Sizes and Penetration Depths
           6.2.3 Side-Button Lancets
                    6.2.3.1 Ease of Use and Anti-Reuse Measures have Made Side-Button Lancets Popular Among End Users
    6.3 Personal Lancets
           6.3.1 Increasing Prevalence of Diabetes has Resulted in Significant Demand for Personal Lancets

7 Lancets Market, By Application (Page No. - 42)
    7.1 Introduction
    7.2 Glucose Testing
           7.2.1 Increasing Diabetes Prevalence is Expected to Drive the Demand for Lancets in Glucose Testing During the Forecast Period
    7.3 Hemoglobin Testing
           7.3.1 High Prevalence of Anemia Expected to Increase Hemoglobin Testing Volume and the Demand for Lancets
    7.4 Coagulation Testing
           7.4.1 Rising Prevalence of Liver Diseases, Thrombophilia, and Hemophilia to Drive the Demand for Coagulation Testing
    7.5 Other Applications
           7.5.1 This Segment Covers Other Applications of Lancets, Such as Pregnancy Testing, Infectious Diseases Testing, and Cholesterol Testing.

8 Lancets Market, By End User (Page No. - 48)
    8.1 Introduction
    8.2 Hospitals & Clinics
           8.2.1 Increasing Incidence of Diseases That Require Blood Testing for Diagnosis and Treatment is Driving the Adoption of Lancets in Hospitals and Clinics
    8.3 Home Care Settings
           8.3.1 Increasing Prevalence of Diabetes is Expected to Drive the Demand for Lancets in the Home Care Settings Segment During the Forecast Period
    8.4 Other End Users

9 Lancets Market, By Region (Page No. - 53)
    9.1 Introduction
    9.2 North America
           9.2.1 High Diabetic Population and Reimbursement Coverage for Lancets Will Drive Market Growth in North America
    9.3 Europe
           9.3.1 Rising Awareness on Diabetes Treatment and Prevention Will Contribute to Lancet Use in Europe
    9.4 Asia Pacific
           9.4.1 Rapid Economic Growth in APAC Countries Will Provide Opportunities for Market Players
    9.5 RoW

10 Competitive Landscape (Page No. - 79)
     10.1 Overview
     10.2 Competitive Leadership Mapping (2018)
             10.2.1 Vendor Inclusion Criteria
             10.2.2 Visionary Leaders
             10.2.3 Innovators
             10.2.4 Dynamic Differentiators
             10.2.5 Emerging Companies

11 Company Profiles (Page No. - 81)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Becton, Dickinson and Company
     11.2 Roche Diagnostics
     11.3 Ypsomed
     11.4 B. Braun Melsungen
     11.5 Terumo Corporation
     11.6 Owen Mumford
     11.7 HTL-Strefa S.A
     11.8 Arkray
     11.9 Sarstedt
     11.10 Sterilance Medical (Suzhou)
     11.11 Medline Industries
     11.12 Intrinsyk

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 99)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (75 Tables)

Table 1 Incidence of Infectious Diseases
Table 2 Lancets Market, By Type, 2017–2024 (USD Billion)
Table 3 Safety Lancets: Market, By Region, 2017–2024 (USD Million)
Table 4 Safety Lancets: Market, By Type, 2017–2024 (USD Million)
Table 5 Push-Button Lancets: Market, By Region, 2017–2024 (USD Million)
Table 6 Pressure-Activated Lancets: Market, By Region, 2017–2024 (USD Million)
Table 7 Side-Button Lancets: Market, By Region, 2017–2024 (USD Million)
Table 8 Personal Lancets: Market, By Region, 2017–2024 (USD Million)
Table 9 Market, By Application, 2017–2024 (USD Million)
Table 10 Market for Glucose Testing, By Region, 2017–2024 (USD Million)
Table 11 Market for Hemoglobin Testing, By Region, 2017–2024 (USD Million)
Table 12 Market for Coagulation Testing, By Region, 2017–2024 (USD Million)
Table 13 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 14 Market, By End User, 2017–2024 (USD Million)
Table 15 Market for Hospitals & Clinics, By Region, 2017–2024 (USD Million)
Table 16 Market for Home Care Settings, By Region, 2017–2024 (USD Million)
Table 17 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 18 Market, By Region, 2017–2024 (USD Million)
Table 19 North America: Market, By Type, 2017–2024 (USD Million)
Table 20 North America: Safety Lancets: Market, By Type, 2017–2024 (USD Million)
Table 21 North America: Market, By Application, 2017–2024 (USD Million)
Table 22 North America: Market, By End User, 2017–2024 (USD Million)
Table 23 Europe: Market, By Type, 2017–2024 (USD Million)
Table 24 Europe: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 25 Europe: Market, By Application, 2017–2024 (USD Million)
Table 26 Europe: Market, By End User, 2017–2024 (USD Million)
Table 27 APAC: Market, By Country, 2017–2024 (USD Million)
Table 28 APAC: Market, By Type, 2017–2024 (USD Million)
Table 29 APAC: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 30 APAC: Market, By Application, 2017–2024 (USD Million)
Table 31 APAC: Market, By End User, 2017–2024 (USD Million)
Table 32 China: Market, By Type, 2017–2024 (USD Million)
Table 33 China: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 34 China: Market, By Application, 2017–2024 (USD Million)
Table 35 China: Market, By End User, 2017–2024 (USD Million)
Table 36 Australia: Market, By Type, 2017–2024 (USD Million)
Table 37 Australia: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 38 Australia: Market, By Application, 2017–2024 (USD Million)
Table 39 Australia: Market, By End User, 2017–2024 (USD Million)
Table 40 South Korea: Market, By Type, 2017–2024 (USD Million)
Table 41 South Korea: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 42 South Korea: Market, By Application, 2017–2024 (USD Thousand)
Table 43 South Korea: Market, By End User, 2017–2024 (USD Million)
Table 44 Indonesia: Market, By Type, 2017–2024 (USD Million)
Table 45 Indonesia: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 46 Indonesia: Market, By Application, 2017–2024 (USD Thousand)
Table 47 Indonesia: Market, By End User, 2017–2024 (USD Million)
Table 48 Malaysia: Market, By Type, 2017–2024 (USD Million)
Table 49 Malaysia: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 50 Malaysia: Market, By Application, 2017–2024 (USD Thousand)
Table 51 Malaysia: Market, By End User, 2017–2024 (USD Million)
Table 52 Thailand: Market, By Type, 2017–2024 (USD Million)
Table 53 Thailand: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 54 Thailand: Market, By Application, 2017–2024 (USD Thousand)
Table 55 Thailand: Market, By End User, 2017–2024 (USD Thousand)
Table 56 Vietnam: Market, By Type, 2017–2024 (USD Thousand)
Table 57 Vietnam: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 58 Vietnam: Market, By Application, 2017–2024 (USD Thousand)
Table 59 Vietnam: Market, By End User, 2017–2024 (USD Thousand)
Table 60 Singapore: Market, By Type, 2017–2024 (USD Thousand)
Table 61 Singapore: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 62 Singapore: Market, By Application, 2017–2024 (USD Thousand)
Table 63 Singapore: Market, By End User, 2017–2024 (USD Thousand)
Table 64 New Zealand: Market, By Type, 2017–2024 (USD Thousand)
Table 65 New Zealand: Safety Lancets Market, By Type, 2017–2024 (USD Thousand)
Table 66 New Zealand: Market, By Application, 2017–2024 (USD Thousand)
Table 67 New Zealand: Market, By End User, 2017–2024 (USD Thousand)
Table 68 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 69 RoAPAC: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 70 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 71 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 72 RoW: Market, By Type, 2017–2024 (USD Million)
Table 73 RoW: Safety Lancets Market, By Type, 2017–2024 (USD Million)
Table 74 RoW: Market, By Application, 2017–2024 (USD Million)
Table 75 RoW: Market, By End User, 2017–2024 (USD Million)


List of Figures (27 Figures)

Figure 1 Lancets Market
Figure 2 Lancets Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Lancets: Market, By Type, 2019–2024
Figure 9 Lancets: Market, By Application, 2019
Figure 10 Lancets: Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Lancets Market
Figure 12 Increasing Incidence Diabetes to Drive the Growth of the Lancets Market
Figure 13 Safety Lancets Held Largest Share of the North American Market, 2018
Figure 14 Push-Button Lancets to Dominate the European Market During the Forecast Period
Figure 15 Asia Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 16 Lancets Market: Drivers, Restraints, Opportunities, & Challenges
Figure 17 Safety Lancets to Witness the Highest Growth in the Lancets Market From 2019 to 2024
Figure 18 Glucose Testing Was the Largest Application Segment in the Lancets Market in 2018
Figure 19 Lancets Market, By End User, 2019 vs 2024 (USD Million)
Figure 20 North America: Lancets Market Snapshot
Figure 21 Asia Pacific: Lancets Market Snapshot
Figure 22 MnM Dive-Vendor Comparison Matrix: Lancets Market
Figure 23 Becton, Dickinson and Company: Company Snapshot
Figure 24 Roche Diagnostics: Company Snapshot
Figure 25 Ypsomed: Company Snapshot
Figure 26 B.Braun: Company Snapshot
Figure 27 Terumo Corporation: Company Snapshot

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the lancets market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the lancets market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from medical devices companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Lancets Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).

Data Triangulation

After arriving at the market size, the lancets market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Objectives of the Study

  • To define, describe, segment, and forecast the global lancets market by type, application, end user, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the lancets market in four main regions along with their respective key countries (North America, Europe, Asia Pacific, and the Rest of the World)
  • To profile key players in the global lancets market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as expansions and collaborations of the leading players in the lancets market

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, Application, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

The research report categorizes the market into the following segments and subsegments:

Lancets Market, by Type

  • Safety Lancets
  • Personal Lancets

Lancets Market, by Application

  • Glucose Testing
  • Hemoglobin Testing
  • Coagulation Testing
  • Other Applications

Lancets Market, by Region

  • North America
  • Europe
  • Asia Pacific
    • China
    • Australia
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Vietnam
    • Singapore
    • New Zealand
    • Rest of Asia Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • A further breakdown of the North American lancets market into the US and Canada
  • A further breakdown of the European lancets market into Germany, the UK, France, and the Rest of Europe
Report Code
MD 7166
Published ON
Jun, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Lancets Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home